Butalb-acetamin-caff 50-300-40 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FL039
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,108
Award facts
- Contract value 100% obligated
- $1,108.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,108.46 to AmerSourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-300-40 mg tablets (100 count) on January 27, 2026, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The parent company's substantial IDC with DLA encompasses an extensive portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for butalbital-based pain management medication represents a routine fulfillment under the larger contract vehicle, demonstrating the contractor's ongoing capability to efficiently supply essential pharmaceutical commodities required by military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FL039?
SPE2DR26FL039 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FL039 worth?
The government has obligated $1,108 on SPE2DR26FL039.
Is contract SPE2DR26FL039 an order under another contract?
Yes. SPE2DR26FL039 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL039 competed?
The extent of competition for SPE2DR26FL039 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award